CD14 and breast carcinoma: It has been reported that in metastatic patients there was increased production of TNF-α and IL-1β [49] compared with early breast cancer patients, and upregulation of CD14 and CD40 [53], two receptors necessary for macrophage pro-inflammatory function and antigen presentation.